Supportive care in hematologic malignancies, including hematopoietic growth factors, transfusions, and infectious complications.
This review focuses on some of the recent developments in the field of supportive care in hematologic malignancies. The increasingly important role of hematopoietic growth factors in modern treatment modalities for hematologic disorders is clear. Newer developments in transfusional therapy and in the management of infectious complications are also discussed.
Fetscher
S
S
Department of Internal Medicine, Freiburg University Medical Center, Germany.
Mertelsmann
R
R
D001803:Blood Transfusion; D003141:Communicable Diseases / Q000209:etiology / Q000628:therapy*; D019337:Hematologic Neoplasms / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans
D016298:Hematopoietic Cell Growth Factors